TOPLINE: Low-dose doxycycline showed comparable efficacy with high-dose treatment in patients with lymphocytic scarring alopecia, with a lower rate of adverse events (AEs) and related discontinuations. METHODOLOGY: Researchers conducted a retrospective review of 241 patients (82.6% women; mean age, 58.4 years; 49.8% White; 14.1% Black) diagnosed with lymphocytic scarring alopecia between 2009 and 2023 to ...
.png)
Market Touch Signal · Finland · international digital desk
+358 400 512311
info@market-touch.org
